HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD40 ligand preferentially modulates immune response and enhances protection against influenza virus.

Abstract
CD40L, a key regulator of the immune system, was studied as both a targeting ligand and a molecular adjuvant in nucleoprotein (NP)-based host defense against influenza in mouse models with different genetic backgrounds. Adenoviral vectors secreting NP-CD40L fusion protein (denoted as rAd-SNP40L) afforded full protection of immunocompetent and immunocompromised mice (CD40L(-/-) and CD4(-/-)) against lethal influenza infection. Mechanistically, rAd-SNP40L preferentially induced early and persistent B cell germinal center formation, and accelerated Ig isotype-switching and Th1-skewed, NP-specific Ab response. Moreover, it drastically augmented primary and memory NP-specific CTL activity and polyfunctional CD8(+) T cells. The markedly enhanced nonneutralizing Abs and CTLs significantly reduced viral burdens in the lungs of mice upon lethal virus challenge. Data generated from CD40L(-/-) and CD4(-/-) mice revealed that the protection was indeed CD40L mediated but CD4(+) T cell independent, demonstrating the viability of the fusion Ags in protecting immunodeficient hosts. Notably, a single dose of rAd-SNP40L completely protected mice from lethal viral challenge 4 mo after immunization, representing the first report, to our knowledge, on NP in conjunction with a molecular adjuvant inducing a robust and long-lasting memory immune response against influenza. This platform is characterized by an increased in vivo load of CD40-targeted Ag upon the secretion of the fusion protein from adenovirus-infected cells and may represent a promising strategy to enhance the breadth, durability, and potency of Ag-specific immune responses.
AuthorsAnwar M Hashem, Caroline Gravel, Ze Chen, Yinglei Yi, Monika Tocchi, Bozena Jaentschke, Xingliang Fan, Changgui Li, Michael Rosu-Myles, Alexander Pereboev, Runtao He, Junzhi Wang, Xuguang Li
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 2 Pg. 722-34 (Jul 15 2014) ISSN: 1550-6606 [Electronic] United States
PMID24928989 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • Nucleoproteins
  • Recombinant Fusion Proteins
  • CD40 Ligand
Topics
  • Adaptive Immunity (genetics, immunology)
  • Adenoviridae (genetics)
  • Animals
  • B-Lymphocytes (immunology, metabolism)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD40 Ligand (deficiency, genetics, immunology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Dogs
  • Female
  • Genetic Vectors (genetics)
  • HEK293 Cells
  • Humans
  • Immunization
  • Influenza A virus (immunology, physiology)
  • Madin Darby Canine Kidney Cells
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NIH 3T3 Cells
  • Nucleoproteins (genetics, immunology, metabolism)
  • Orthomyxoviridae Infections (genetics, immunology, virology)
  • Recombinant Fusion Proteins (genetics, immunology, metabolism)
  • Survival Analysis
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: